Marieke van Son

20 CHAPTER 1 32. Pasoglou V, Larbi A, Collette L, Annet L, Jamar F, Machiels JP, et al. One- step TNM staging of high-risk prostate cancer using magnetic resonance imag- ing (MRI): toward an upfront simplified “all-in-one” imaging approach? The Prostate. 2014;74(5):469-77. 33. Hicks RJ, Murphy DG, Williams SG. Se- duction by Sensitivity: Reality, Illusion, or Delusion? The Challenge of Assess- ing Outcomes after PSMA Imaging Selection of Patients for Treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medi- cine. 2017;58(12):1969-71. 34. Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Pros- tate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208-16. 35. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Local- ized Prostate Cancer. N Engl J Med. 2016;375(15):1415-24. 36. Myers RP. Practical surgical anat- omy for radical prostatectomy. The Urologic clinics of North America. 2001;28(3):473-90. 37. Ramsay C, Pickard R, Robertson C, Close A, Vale L, Armstrong N, et al. System- atic review and economic modelling of the relative clinical benefit and cost-ef- fectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. Health technology assessment. 2012;16(41):1-313. 38. Alibhai SM, Leach M, Tomlinson G, Krahn MD, Fleshner N, Holowaty E, et al. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. Journal of the National Cancer Institute. 2005;97(20):1525-32. 39. Haglind E, Carlsson S, Stranne J, Waller- stedt A, Wilderang U, Thorsteinsdottir T, et al. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial. Eur Urol. 2015;68(2):216-25. 40. Sutherland DE, Linder B, Guzman AM, Hong M, Frazier HA, 2nd, Engel JD, et al. Posterior rhabdosphincter reconstruc- tion during robotic assisted radical prostatectomy: results from a phase II randomized clinical trial. The Journal of urology. 2011;185(4):1262-7. 41. Stolzenburg JU, Nicolaus M, Kallidonis P, Do M, Dietel A, Hafner T, et al. Influence of bladder neck suspension stitches on early continence after radical prostatec- tomy: a prospective randomized study of 180 patients. Asian journal of andrology. 2011;13(6):806-11. 42. Walz J, Epstein JI, Ganzer R, Graefen M, Guazzoni G, Kaouk J, et al. A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Relat- ed to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update. Eur Urol. 2016;70(2):301-11. 43. Stolzenburg JU, Kallidonis P, Do M, Dietel A, Hafner T, Rabenalt R, et al. A compar- ison of outcomes for interfascial and intrafascial nerve-sparing radical pros- tatectomy. Urology. 2010;76(3):743-8. 44. Zaorsky NG, Harrison AS, Trabulsi EJ, Gomella LG, Showalter TN, Hurwitz MD, et al. Evolution of advanced technologies in prostate cancer radiotherapy. Nature reviews Urology. 2013;10(10):565-79. 45. Matzinger O, Duclos F, van den Bergh A, Carrie C, Villa S, Kitsios P, et al. Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. European journal of cancer. 2009;45(16):2825-34.